https://ki.se RSS News Listing https://news.ki.se/getting-the-right-breast-cancer-therapy-to-the-right-patient Over 1,300 women are still dying of breast cancer in Sweden every year. Theodoros Foukakis is trying to understand the tumour properties that determine the success of a particular treatment in order to achieve greater therapeutic precision. Meet one of the new professors of Karolinska Institutet who will participate in this year's installation ceremony at Aula Medica on 9 October. Tue, 16 Sep 2025 10:00:11 +0200 https://news.ki.se/three-out-of-ten-breast-cancers-are-detected-between-screenings In a new study, researchers from Karolinska Institutet have shown that so-called interval cancers, which are detected between two screening sessions, account for a significant proportion of breast cancer cases and that certain risk factors may increase the likelihood of developing this type of cancer. The study was published in the journal JAMA Oncology. Fri, 28 Mar 2025 13:23:47 +0100 https://news.ki.se/andri-papakonstantinou-receives-scholarship-from-swedish-society-of-oncology Andri Papakonstantinou has been awarded the Pfizer and Swedish Society of Oncology’s (SOF) research scholarship in oncology for postdoctoral researchers in 2025. The scholarship was presented at SOF's annual meeting in Sundsvall on March 20th. Thu, 20 Mar 2025 16:11:29 +0100 https://news.ki.se/ai-analysis-of-immune-cells-can-predict-breast-cancer-prognosis Researchers at Karolinska Institutet have investigated how well different AI models can predict the prognosis of triple-negative breast cancer by analysing certain immune cells inside the tumour. The study, published in the journal eClinicalMedicine, is an important step towards using AI in cancer care to improve patient health. Mon, 18 Nov 2024 14:26:28 +0100 https://news.ki.se/svenska-lakaresallskapet-awards-adjunct-professor-jana-de-boniface-their-prestigious-jubilee-prize-2024 Svenska Läkaresällskapet (the Swedish Medical Society, SLS) has decided to award Jana de Boniface, adjunct professor at Karolinska Institutet and senior physician and surgeon at the surgery and oncology clinic, Capio St. Göran's Hospital, with their prestigious Jubilee Prize. The awardee is rewarded with SEK 175,000 and the SLS century medal in silver. Mon, 07 Oct 2024 11:45:16 +0200 https://news.ki.se/increasing-incidence-of-cancer-during-pregnancy-yet-maternal-and-perinatal-risks-are-low Although the incidence of cancer during pregnancy is increasing in Sweden, new studies from Karolinska Institutet show that women with breast cancer during pregnancy have good prognosis and low risks of adverse obstetric and perinatal outcomes. Thu, 22 Aug 2024 10:56:18 +0200 https://news.ki.se/improved-survival-for-breast-cancer-patients-with-dose-dense-chemotherapy Dose-dense adjuvant chemotherapy can improve survival for patients with high-risk breast cancer, according to researchers at Karolinska Institutet and others. The international PANTHER study, which included over 2000 patients where 97% had metastasis to the lymph nodes in the armpit, compared two different chemotherapy regimens and found that the dose-intensive treatment reduced the risk of recurrence and spread of the disease. The results are presented in the Journal of Clinical Oncology. Wed, 21 Aug 2024 07:56:18 +0200 https://news.ki.se/exercise-program-improves-quality-of-life-for-metastatic-breast-cancer-patients A new study published in Nature Medicine shows that partic-ipating in an exercise program can reduce pain and fatigue, and improve the quality of life for individuals with metastatic breast cancer. Tue, 20 Aug 2024 09:56:43 +0200 https://news.ki.se/study-opens-the-door-to-new-treatment-strategies-for-breast-cancer In a study published in Nature Communications, scientists have made significant strides in understanding the complex interplay between the immune system and cancer metabolism in breast cancer treatment. The research offers new insights into how the immune state and cancer metabolism evolve during neoadjuvant chemotherapy (NAC). Mon, 27 May 2024 08:13:09 +0200 https://news.ki.se/psychiatrist-ullakarin-nyberg-was-herself-affected-by-breast-cancer Ullakarin Nyberg is a researcher at the Center for Psychiatry Research at Karolinska Institutet. She also works clinically as a psychiatrist, part of the time at a unit for breast cancer patients. At the end of 2018, she contracted the disease herself. Thu, 21 Mar 2024 16:25:15 +0100 https://news.ki.se/exercise-tested-against-breast-cancer Can breast cancer patients who exercise get better results from their chemotherapy? And if so, should they receive treatment that includes exercise? This will be investigated in an international study led by researcher Jana de Boniface. Thu, 21 Mar 2024 16:12:13 +0100 https://news.ki.se/diet-and-breast-cancer-alcohol-increases-the-risk It is difficult to draw firm conclusions about how to eat and drink to avoid breast cancer. Dietary studies often rely on self-reporting, while dietary habits change over the course of a lifetime - both of which are complicated for researchers. But one link is well documented: even moderate alcohol consumption increases the risk of developing the disease, says Professor Alicja Wolk. Thu, 21 Mar 2024 15:58:16 +0100 https://news.ki.se/what-causes-breast-cancer There is a lot going on in breast cancer research. A new AI tool is trying to fine-tune the screening program, another is helping pathologists make diagnoses, and new drugs are being tested and approved. This could save more lives. But there is still no answer to the trickiest question of all: Why does breast cancer occur? Thu, 21 Mar 2024 15:44:36 +0100 https://news.ki.se/future-cancer-treatment-and-fertility In recent years, the treatment landscape for solid tumors has undergone a notable change. With new cancer treatments, the future looks brighter for many young cancer patients, making fertility issues and future family planning an important aspect. Six specialists in oncology and onco-fertility at the Department of Oncology-Pathology join forces to compile knowledge and recommendations on this important issue. Wed, 13 Mar 2024 07:51:27 +0100 https://news.ki.se/inherited-genetic-mutations-can-predict-interval-breast-cancer An investigation conducted by researchers at Karolinska Institutet has led to a discovery in breast cancer diagnostics and treatments that could reshape screening programs and clinical approaches. The study, published in JAMA Oncology, unravels the impact of rare genetic variants on interval breast cancers, providing new insights into tailored screening strategies. Thu, 25 Jan 2024 17:06:19 +0100 https://news.ki.se/ai-can-identify-women-with-high-risk-of-breast-cancer-in-screening-examinations The use of AI makes it possible for women with a high risk of breast cancer to be identified in mammography screening examinations so that the cancer can be caught earlier. An international research group led from Karolinska Institutet in Sweden can now show that the method is effective in different European countries. The study is published in The Lancet Regional Health – Europe. Thu, 07 Dec 2023 00:30:05 +0100 https://news.ki.se/paradoxical-role-of-white-blood-cells-in-breast-cancer-spread A new study from Karolinska Institutet published in Cell reports shows that tumor-associated macrophages, which are white blood cells that are found in breast tumors, can both help and hinder the spread of cancer cells to other organs. The researchers found that macrophages that produce a substance called VEGF-C reduce the spread of breast cancer to the lungs but increase the spread to the lymph nodes. This may have implications for the prognosis and treatment of breast cancer. Mon, 04 Dec 2023 12:21:39 +0100 https://news.ki.se/new-way-to-kill-breast-cancer-stem-cells-that-have-ancestral-features-and-resist-chemotherapy Researchers at Karolinska Institutet and Kanazawa University in Japan have made a new discovery which could improve breast cancer treatments. The researchers studied cancer stem cells (CSCs), which can resist chemotherapy and form new tumors. They found a type of CSCs that are vulnerable to drugs that target a pump in the cells. These drugs could potentially kill these CSCs and help patients with triple-negative breast cancer (TNBC), a hard-to-treat form of breast cancer. Fri, 24 Nov 2023 07:59:20 +0100 https://news.ki.se/higher-risk-of-breast-cancer-in-women-with-false-positive-mammography-result Women who receive a false positive mammography result are more likely to develop breast cancer over the subsequent 20 years, report researchers from Karolinska Institutet in a study published in JAMA Oncology. The risk is highest for women aged between 60 and 75 and who have low breast density. Thu, 02 Nov 2023 16:05:08 +0100 https://news.ki.se/epidemiological-studies-on-breast-cancer-risk-factors-and-screening A new thesis from Karolinska Institutet focuses on cancer prevention by investigating the factors and outcomes associated with false-positive mammography recalls, a fairly common event where women are called back for additional tests after an initial screening, but no cancer is detected during the follow-up. A second aim of the thesis was to further our understanding of the association between breast cancer risk factors in women and cancer risk among their relatives, particularly sisters. Wed, 18 Oct 2023 14:10:29 +0200 https://news.ki.se/more-cases-of-breast-cancer-can-be-found-with-the-help-of-ai One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital Health. The researchers say that AI is now ready to be implemented in breast cancer screening. Sat, 09 Sep 2023 00:30:07 +0200 https://news.ki.se/beyond-mammography-complementary-methods-in-breast-imaging Breast cancer is the most common cancer among women and the likelihood of surviving the disease is higher if the cancer is detected early and the tumour is relatively small and not very aggressive. Tue, 09 May 2023 09:35:51 +0200 https://news.ki.se/adjuvant-hormone-therapy-in-breast-cancer-patients-why-do-women-discontinue-treatment-and-what-are-the-consequences Breast cancer is the most common cancer affecting women and many women are being treated to prevent the cancer from returning, for example with adjuvant hormone therapy. This therapy is prescribed as a once-a-day pill for estrogen receptor-positive breast cancer patients (around 80% of all cases) for a duration of at least five years. Thu, 27 Apr 2023 08:46:26 +0200 https://news.ki.se/now-local-hospitals-can-determine-how-ai-systems-would-detect-breast-cancer While there are currently a dozen approved AI systems for breast cancer screening, it has been difficult to evaluate their clinical performance objectively. Now, however, there is a Swedish validation platform ready to compare how well AI systems detect signs of breast cancer – and its development has been led by researchers at Karolinska Institutet. Mon, 20 Mar 2023 16:50:04 +0100 https://news.ki.se/new-method-finds-the-right-treatment-for-breast-cancer-patients Researchers at Karolinska Institutet have developed a method that should be able to predict whether a patient with breast cancer will benefit from a particular treatment or not. The cell-based method has been tested on patients with promising results, according to a study published in PNAS. Tue, 27 Dec 2022 07:00:04 +0100 https://news.ki.se/developing-artificial-intelligence-tools-for-breast-cancer-precision-pathology Breast cancer is the most common cancer type in women globally, but there is a continuous decline in mortality rates. A partial explanation for this may be that effective treatments are being developed for subgroups of breast cancer patients. It is still challenging to optimise treatment plans for every individual. Mon, 28 Nov 2022 13:17:42 +0100 https://news.ki.se/ki-researchers-awarded-for-ai-based-image-analysis-in-breast-cancer-diagnostics Two researchers at Karolinska Institutet have been awarded the Athena prize for an AI-based image analysis in precision medicine for risk classification of breast cancer patients. The Athena Prize is Sweden's largest prize for research and innovations that have been produced through collaboration between healthcare, academia and industry. Wed, 19 Oct 2022 12:35:12 +0200 https://news.ki.se/fertility-preservation-measures-do-not-appear-to-increase-the-risk-of-breast-cancer-recurrence Women with a breast cancer diagnosis undergoing procedures for fertility preservation are not at increased risk of recurrence of the disease or disease-specific mortality. This has been shown in a study by Karolinska Institutet that followed the participants for five years on average. The results, published in the journal JAMA Oncology, could in the future provide safety and new hope to women who want to preserve their fertility after cancer treatment with chemotherapy. Thu, 25 Aug 2022 17:00:07 +0200 https://news.ki.se/hormonal-breast-cancer-treatment-reduces-long-term-risk-of-recurrence To investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet have done a 20-year follow-up of premenopausal women with breast cancer. The study, published in the Journal of Clinical Oncology, indicates that the treatment provides protection even after a longer period of time and that different patients seem to benefit from different hormonal treatments. Tue, 02 Aug 2022 14:58:53 +0200 https://news.ki.se/breast-cancer-natural-history-models-and-risk-prediction-in-mammography-screening-cohorts In a new thesis, Rickard Strandberg, PhD student at the Department of Medical Epidemiology and Biostatistics, lays the foundations for a new natural history model for breast cancer. By taking advantage of available detailed screening cohorts, Rickard’s work includes three diverse applications of this model. Wed, 20 Apr 2022 11:48:52 +0200 https://news.ki.se/study-identifies-new-protection-mechanism-in-breast-cancer Researchers at Karolinska Institutet have identified a protein that protects against breast tumour growth and that can be linked to a better prognosis in breast cancer patients. The results, which are published in the journal Nature Communications, may contribute to the development of new therapies for difficult-to-treat forms of breast cancer. Tue, 22 Mar 2022 11:01:08 +0100 https://news.ki.se/cervical-samples-could-reveal-risk-of-breast-and-ovarian-cancer An international team of scientists, including from Karolinska Institutet, has discovered a means of identifying the risk of breast and ovarian cancer by analysing cell samples from the cervix. By measuring epigenetic changes in cervical samples from over a thousand women, the researchers have found two unique signatures for breast and ovarian cancer. The results are presented in two papers in the journal Nature Communications. Fri, 04 Feb 2022 08:50:40 +0100 https://news.ki.se/over-a-quarter-of-a-billion-sek-for-cancer-research-at-ki 79 KI researchers have received a total of SEK 254,450,000 in grants from the Swedish Cancer Society. In addition, four Fellowship prevention grants were also awarded to researchers at KI. In total, the Swedish Cancer Society distributed SEK 850 million, which is the largest amount ever. Thu, 09 Dec 2021 09:29:05 +0100 https://news.ki.se/per-hall-praised-for-his-research-on-breast-cancer-prevention The Breast Cancer Association's award 2021 goes to chief physician and KI professor Per Hall. He is recognized for his broad research on how breast cancer can be prevented and detected early with refined and individual methods. Tue, 23 Nov 2021 17:04:30 +0100 https://news.ki.se/20-msek-from-the-swedish-research-council-to-mmk Congratulations to five researchers at the Department of Molecular Medicine and Surgery who received funding from the Swedish Research Council within the field Medicine and Health at the dividend on October 28, 2021. Mon, 01 Nov 2021 10:50:31 +0100 https://news.ki.se/ai-improves-precision-in-breast-cancer-diagnosis Researchers at Karolinska Institutet have developed an AI-based tool that improves the diagnosis of breast cancer tumours and the ability to predict the risk of recurrence. The greater diagnostic precision can lead to more personalised treatment for the large group of breast cancer patients with intermediate risk tumours. The results are published in the scientific journal Annals of Oncology. Thu, 30 Sep 2021 01:05:04 +0200 https://news.ki.se/new-marker-predicts-benefit-of-radiotherapy-for-early-stage-breast-cancer A study involving researchers at Karolinska Institutet and University of Gothenburg has found that low levels of a protein called PDGFRb are associated with particularly good results of radiotherapy in women with early-stage breast cancer. The study, which is published in the journal Clinical Cancer Research, also suggests that the efficacy of radiotherapy can be improved with drugs that block this protein. Wed, 05 May 2021 09:05:05 +0200 https://news.ki.se/lower-dose-of-oestrogen-receptor-modulator-seems-to-reduce-risk-of-breast-cancer While the drug tamoxifen reduces the risk of developing breast cancer and prevents recurrence, the side-effects cause many women to discontinue their treatment. A study involving researchers at Karolinska Institutet in Stockholm has now found that a much lower dose than the standard produces a good effect with fewer adverse reactions in women who have yet to enter the menopause. The study, which has been published in the Journal of Clinical Oncology, can play a significant role in the treatment. Thu, 18 Mar 2021 21:00:04 +0100 https://news.ki.se/new-insights-on-how-immune-cells-are-recruited-and-reprogrammed-to-drive-tumor-development Researchers at Karolinska Institutet show how a certain type of immune cells, macrophages, can be recruited into breast cancer tumors, where they are reprogrammed to support and drive tumor growth. In a study published in the scientific journal PNAS, they describe that low levels of the tumor suppressor protein TAp73 lead to hyperactivation of NFkB signaling and an inflammatory condition in breast cancer as well as secretion of molecules that recruit tumor-promoting macrophages into the tumor. Tue, 02 Mar 2021 09:36:17 +0100 https://news.ki.se/introducing-rebecca KI is participating in a new EU project about using Real World Data (RWD) to improve post treatment in breast cancer, as well as shaping guidelines and best practices for researchers, public health and regulatory bodies throughout Europe to facilitate wider adaption of RWD in research and clinical practice. Thu, 04 Feb 2021 17:02:58 +0100 https://news.ki.se/risk-assessment-and-prevention-of-breast-cancer One woman in eight develops breast cancer during her lifetime in the Western world and although mammography screening reduces mortality by early detection, approximately one fourth of the women who develop breast cancer are diagnosed within two years after a negative screen. Fri, 08 Jan 2021 09:23:26 +0100 https://news.ki.se/mobile-app-reduced-experienced-symptoms-in-breast-cancer-patients Hi there Maria Fjell, researcher at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet who recently defended her thesis “Supportive care for patients with breast cancer by using an interactive app during neoadjuvant chemotherapy – a Randomized Controlled Trial”. What’s the main focus of the thesis? Mon, 04 Jan 2021 08:38:38 +0100 https://news.ki.se/breast-cancer-risk-determinants-and-influence-of-mammographic-features In her thesis, Shadi Azam studied the association between established breast cancer risk factors with mammographic density change over time and mammographic microcalcifications by using data from the prospective KARMA cohort. Fri, 20 Nov 2020 13:36:37 +0100 https://news.ki.se/frozen-eggs-and-ovarian-tissue-helped-women-conceive-children-after-breast-cancer Women with breast cancer whose eggs or ovarian tissue were frozen had more children after their diagnosis than women who did not undergo fertility preservation using those methods before start of cancer treatment. That is according to a study by researchers at Karolinska Institutet in Sweden, published in JAMA Oncology. According to the researchers, the result highlights the importance of reproductive counseling and fertility preservation for women who are diagnosed with cancer at a young age. Thu, 19 Nov 2020 17:00:04 +0100 https://news.ki.se/improved-survival-for-cancer-patients-in-a-large-nordic-comparison A comprehensive comparison of cancer survival between the Nordic countries shows improvements for all countries over time with previously observed differences attenuated. The reasons for these improvements are likely multifactorial. Previous studies comparing cancer survival between the Nordic countries have found marked differences, with a notably poorer survival in Danish patients. Mon, 19 Oct 2020 13:06:33 +0200 https://news.ki.se/molecular-epidemiology-studies-on-risk-factors-and-aggressive-breast-cancer In his thesis, Emilio Ugalde Morales uses a molecular epidemiology approach to investigate the association between risk factors and aggressive breast cancer defined by tumor characteristics, intrinsic subtypes, mode of detection, and survival. Wed, 16 Sep 2020 09:05:06 +0200 https://news.ki.se/ai-as-good-as-the-average-radiologist-in-identifying-breast-cancer Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms. The best algorithm proved to be as accurate as the average radiologist. The results, published in JAMA Oncology, may lead the way in reorganising breast cancer screening for the future. Thu, 27 Aug 2020 17:00:04 +0200 https://news.ki.se/breast-density-microcalcifications-and-masses-may-be-heritable-traits Some mammographic features - breast density, microcalcifications, and masses - are associated with increased breast cancer risk Thu, 02 Apr 2020 09:30:05 +0200 https://news.ki.se/research-programmes-for-groundbreaking-treatment-and-diagnosis Two new research programmes focusing on AI and bioelectronic medicine, for application in the areas of breast cancer and inflammatory disease, respectively, have been adopted at MedTechLabs. An interdisciplinary centre run by KTH, Karolinska Institutet and the Stockholm Region. Mon, 13 Jan 2020 17:07:43 +0100 https://news.ki.se/thesis-on-statistical-models-of-breast-cancer-tumour-growth-and-spread On Tuesday December 10, Gabriel Isheden will defend his thesis Statistical models of breast cancer tumour growth and spread". Mon, 18 Nov 2019 11:07:38 +0100 https://news.ki.se/new-signaling-pathway-controlling-breast-cancer Cells exposed to cancer-driving mutations respond by triggering a stress reaction called cellular senescence, which halts cell proliferation and thereby constitutes the major protective barrier to cancer. Researchers at Karolinska Institutet have now discovered a previously unknown signaling pathway that controls cellular senescence in breast cancer. Fri, 09 Aug 2019 11:41:10 +0200 https://news.ki.se/hormonal-therapy-has-a-long-term-effect-in-breast-cancer Researchers at Karolinska Institutet in Sweden have investigated the long-term effect of hormonal therapy in women with the most common types of hormone-sensitive breast cancer. The results, presented in the journal JAMA Oncology, show that the treatment has a protective effect against distant metastatic cancer for both so-called Luminal A and Luminal B breast cancer subtypes, and a long-term effect for women diagnosed with Luminal A cancer. Fri, 09 Aug 2019 08:50:59 +0200 https://news.ki.se/identification-of-mechanisms-controlling-fibroblast-functions-in-ductal-breast-carcinoma-in-situ Carina Strell and colleagues in the Arne Östman research group has published an article in Journal of the National Cancer Institute investigating mechanisms controlling fibroblast functions in ductal breast carcinoma in situ (DCIS). Tue, 30 Apr 2019 09:31:51 +0200 https://news.ki.se/cxcl14ackr2-signaling-in-the-tumor-microenvironment-enhance-metastasis-and-shorten-survival-of-breast-cancer-patients In the present study Elin Sjöberg and colleagues in the Arne Östman research group have identified that cancer associated fibroblast (CAF)-produced CXCL14 re-activates a developmental program that promote migration and invasion of cancer cells, leading to increased formation of lung metastasis in mice. They also identified a novel CXCL14-signaling component, ACKR2, which is important for the tumor-promoting effects of CXCL14. Mon, 29 Apr 2019 12:12:51 +0200 https://news.ki.se/proteome-picture-of-breast-cancer In a new study, led by Professor Janne Lehtiö (SciLifeLab/Karolinska Institutet), researchers from SciLifeLab, University of Oslo, and MD Anderson Cancer Center have generated a detailed map of protein levels in breast tumors. The proteome complements the previously known DNA and RNA picture of breast cancer and sheds light on how different mutations give rise to changes on the protein level. Mon, 15 Apr 2019 10:21:23 +0200 https://news.ki.se/jonas-bergh-receives-first-esmo-breast-cancer-award Tue, 02 Apr 2019 10:28:43 +0200 https://news.ki.se/autologous-fat-transfer-can-reduce-radiation-induced-fibrosis-in-breast-cancer-patients Tue, 26 Mar 2019 09:14:04 +0100 https://news.ki.se/no-increased-risk-of-recurrence-in-breast-cancer-after-reconstruction-with-abdominal-tissue Mon, 23 Apr 2018 12:51:41 +0200 https://news.ki.se/aggressive-breast-cancer-has-resistant-tumour-cells-already-prior-to-chemotherapy Thu, 19 Apr 2018 18:01:00 +0200 https://news.ki.se/ki-researchers-awarded-grants-from-the-swedish-childhood-cancer-foundation Thu, 19 Apr 2018 08:49:49 +0200 https://news.ki.se/aggressive-breast-cancer-can-be-transformed-into-a-treatable-form Mon, 12 Mar 2018 18:20:16 +0100 https://news.ki.se/breast-cancers-spread-routes-mapped Tue, 27 Feb 2018 08:00:00 +0100 https://news.ki.se/factor-that-doubles-the-risk-of-death-from-breast-cancer-identified Fri, 19 Jan 2018 08:00:00 +0100 https://news.ki.se/new-way-to-target-the-growth-of-breast-cancer-cells Wed, 17 Jan 2018 13:48:49 +0100 https://news.ki.se/clinical-utility-of-gene-signatures-in-breast-cancer-patients Nick Tobin, Arian Lundberg and colleagues have shown the broad clinical utility of the Recurrence Score and PAM50 breast cancer gene signatures in two papers published simultaneously in Clinical Cancer Research. Wed, 06 Dec 2017 14:17:33 +0100 https://news.ki.se/breast-cancer-recurrence-risk-lingers-longer-than-expected Thu, 09 Nov 2017 06:00:00 +0100 https://news.ki.se/fertility-preservation-with-hormone-stimulation-did-not-increase-risk-of-breast-cancer-relapse Mon, 06 Nov 2017 14:24:42 +0100 https://news.ki.se/test-identifies-breast-cancer-patients-with-very-low-risk-of-death Thu, 29 Jun 2017 17:30:00 +0200 https://news.ki.se/new-potential-target-for-breast-cancer-treatment Researchers at OnkPat have found that breast cancer stem cells are dependent on a certain estrogen receptor to survive. The findings, which are presented in Journal of the National Cancer Institute opens up for new treatment strategies for breast cancer. Fri, 10 Mar 2017 09:37:19 +0100 https://news.ki.se/tailored-dense-dose-chemotherapy-for-early-breast-cancer-does-not-result-in-significant-improvement-in-recurrence-free-survival-0 Among women with high-risk early breast cancer, the use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy did not result in a statistically significant improvement in breast cancer recurrence-free survival, and nonhematologic toxic effects were more frequent in the tailored dose-dense group, according to a study appearing in the November 8 issue of JAMA. Mon, 14 Nov 2016 14:45:24 +0100 https://news.ki.se/how-a-particular-gene-protects-against-aggressive-breast-cancer Tue, 09 Aug 2016 14:46:42 +0200 https://news.ki.se/newly-discovered-mechanism-may-restrict-breast-cancer-growth Charlotte Rolny and colleagues at the Department of Oncology-Pathology have discovered a new mechanism that could be the key to a new strategy to restrict breast cancer growth. Wed, 08 Jun 2016 14:28:16 +0200 https://news.ki.se/potential-effects-of-fertility-treatments-on-breast-density-and-cancer-risk Wed, 13 Apr 2016 10:02:21 +0200 https://news.ki.se/51-million-sek-to-13-researchers-at-the-department Wed, 04 Nov 2015 17:03:26 +0100 https://news.ki.se/per-hall-awarded-a-framework-grant-in-clinical-therapy-research Mon, 08 Dec 2014 14:37:55 +0100 https://news.ki.se/important-factor-in-metastasis-of-breast-cancer-mapped Tue, 20 Aug 2013 00:00:00 +0200 https://news.ki.se/link-between-cadmium-in-food-and-breast-cancer Thu, 15 Mar 2012 00:00:00 +0100 https://news.ki.se/lower-risk-of-breast-cancer-occurrence-but-higher-mortality-amongst-low-educated-and-immigrant-women Low-educated and immigrant women run a lower risk of breast cancer occurrence than highly educated women and women born in Sweden. However, the risk of dying from breast cancer is higher for those low-educated and immigrant women that do get the diagnose – a development that has occurred in Sweden during the last ten years. This according to a new study from the Karolinska Institutet based on the records of some 5 million women between 1961 and 2007. Tue, 10 Jan 2012 00:00:00 +0100